Panbela Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$25,263,000 over the previous period. Total operating expenses were $25,647,000.
Profit Margin
| 2014 | 1.35M | -107.04K | -7.89% |
|---|---|---|---|
| 2015 | 0 | -4.92M | |
| 2016 | 0 | -5.11M | |
| 2017 | 0 | -10.37M | |
| 2018 | 0 | -5.90M | |
| 2019 | 0 | -6.2M | |
| 2020 | 0 | -4.76M | |
| 2021 | 0 | -10.13M | |
| 2022 | 0 | -34.93M | |
| 2023 | 0 | -25.26M |
PBLA Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.35M |
Cost of revenue | 25.64M | 35.73M | 10.01M | 5.75M | 4.32M | 3.89M | 6.01M | 5.16M | 5.44M | 595.15K |
Gross profit | -25.64M | -35.73M | -10.01M | -5.75M | -4.32M | -3.89M | -6.01M | -5.16M | -5.44M | 761.84K |
Operating exp. | ||||||||||
Research and development | 20.61M | 28.04M | 5.42M | 2.50M | 2.34M | 1.78M | 2.59M | 2.50M | 2.85M | 2.36K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -217K | 0 |
Total operating expenses | 25.64M | 34.09M | 10.01M | 5.75M | 4.32M | 3.83M | 6.01M | 5.16M | 5.44M | 837.24K |
Operating income | -51.29M | -34.09M | -10.01M | -5.75M | -4.32M | -3.89M | -6.01M | -5.16M | -5.44M | -75.39K |
Other income (expenses), net | 25.84M | -956K | -613K | 691K | -2.29M | -508K | -4.89M | -107K | -564K | -31.52K |
Income before tax | -25.44M | -35.04M | -10.62M | -5.06M | -6.61M | -6.15M | -10.91M | -5.45M | -5.68M | -106.92K |
Income tax expense | -186K | -116K | -488K | -295K | -415K | -254K | -536K | -341K | -756K | 121 |
Net income | -25.26M | -34.93M | -10.13M | -4.76M | -6.2M | -5.90M | -10.37M | -5.11M | -4.92M | -107.04K |
Earnings per share | ||||||||||
Basic EPS | -232.42K | -40.74K | -20.77K | -14.79K | -26.10K | -1.51K | -3.49K | -1.97K | -4.20K | -892.03 |
Diluted EPS | -232.42K | -40.74K | -20.77K | -14.79K | -26.10K | -1.51K | -3.49K | -1.97K | -4.20K | -892.03 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |